| answer text |
<p>Any company meeting the standards for the manufacture of unlicensed medicinal products,
can supply cannabis-based products for medicinal use.</p><p>Cannabis-based products
for medicinal use are Schedule 2 controlled drugs under the Misuse of Drugs Regulations
2001, which means that manufacturers, importers and distributors of these products
must hold valid Home Office and Medicines and Healthcare products Regulatory Agency
(MHRA) licences for the relevant activities which will include possession, supply
and production of controlled drugs. Where products are sourced from abroad, importers
must obtain an import licence from the Home Office and the MHRA each time they import
these products.</p>
|
 |
